Published on:

Zyprexa warning labels expanded

Eleven years after the drug hit the market and twelve years after a large study indicated that use of the drug increased risks for weight gain and diabetes, pharmaceutical manufacturer Eli Lilly has finally expanded its warning labels on its best selling product Zyprexa. The makers of Zyprexa finally bowed to pressure by the FDA and the warning labels now include risk factors for weight gain, high cholesterol, high blood sugar, and other metabolic problems. Zyprexa has been the subject of numerous product liability lawsuits.

For the full article.